The phytochemistry of Ochna serrulata (Hochst.) Walp. was investigated for the first
time; two new dimeric chalcones (5-deoxyurundeuvine C and serrulone A) and two
new biflavonoid derivatives (4,4’,7-tri-O-methylisocampylospermone A and 4”’-de-Omethylafzelone
A) were isolated. These compounds were isolated along with the
known compounds lophirone A, afzelone B, campylospermone A,
isocampylospermone A, ochnaflavone, 2”,3”-dihydroochnaflavone, lophirone C,
psilosin, 3’-O-methylpsilosin, a cyanoglucoside, epicatechin, (2’,4’-
dihydroxyphenyl)acetic acid, methyl (2’,4’-dihydroxyphenyl)acetate, irisolone 4’-
methyl ether, iriskumaonin 3’-methyl ether, 3',4'-dimethoxy-6,7-methylenedioxyisoflavone, lophirone L, syringaresinol and 16α,17-dihydroxy-entkauran-19-oic acid.
The growth inhibitory effect of these compounds was evaluated against three cancer
cell line panel of TK 10 (renal), UACC62 (melanoma) and MCF7 (breast) using a
sulforhodamine B (SRB) assay. Ochnaflavone and 3’-methoxypsilosin demonstrated
selectivity and only inhibited the growth of melanoma cancer cells. However,
ochnaflavone showed higher activity by totally inhibiting the growth of melanoma
cancer cells at 12.91 μM, whereas, 3’-O-methylpsilosin has this effect at a
concentration of 14.11 μM. Lophirone C, a dimeric chalcone, demonstrated the
highest cytotoxic activity amongst all isolated compounds against renal, melanoma
and breast cancer cells with TGI at 35.63 μM, 11.67 μM and 30.35 μM, respectively.
Lophirone A, a rearranged biflavonoid, showed TGI against these cancer cells at
58.96 μM, 26.23 μM and 40.01 μM, respectively. The rest of the compounds showed
no significant cytotoxicity against the three cancer cells.
The new biflavonoid, 4,4’,7-tri-O-methylisocampylospermone A demonstrated the
highest antimalarial activity against chloroquine-resistant strains of Plasmodium
falciparum (FCR-3) with IC50 of 11.46 μM, followed by ochnaflavone (17.25 μM).
iv
Serrulone A (26.52 μM), lophirone A (29.78 μM), 5-deoxyurundeuvine C (31.07 μM),
lophirone C (35.31 μM), 4”’-de-O-methylafzelone A (38.43 μM), afzelone B (39.54
μM), irisolone 4’-methyl ether (40.72 μM) and syringaresinol (42.66 μM) were
moderately active. The following compounds exhibited the lowest antimalarial activity,
2”,3”-dihydroochnaflavone (61.86 μM), iriskumaonin 3’-O-methyl ether (93.69 μM),3’-
O-methylpsilosin (106.35 μM) and16α,17-dihydroxy-ent-kauran-19-oic acid (106.48
μM).
Owing to the observed and reported biological/pharmacological activity, ochnaflavone
(an ether-linked biflavone consisting of apigenin and luteolin moieties) was selected
for synthetic studies. An older method, nucleophilic aromatic substitution (SNAr) was
successfully applied in the construction of the diary ether. Oxidative ring cyclization of
the ether-linked dimeric chalcone was achieved by using heated pyridine and iodine.
The two methods can be extended further in the synthesis of other novel biflavones
with ether linkage. / Thesis (Ph.D.)-University of KwaZulu-Natal, Pietermaritzburg, 2012.
| Identifer | oai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:ukzn/oai:http://researchspace.ukzn.ac.za:10413/8586 |
| Date | January 2012 |
| Creators | Ndoile, Monica Mbaraka. |
| Contributors | Van Heerden, Fanie R. |
| Source Sets | South African National ETD Portal |
| Language | en_ZA |
| Detected Language | English |
| Type | Thesis |
Page generated in 0.0021 seconds